Jury out on UK gene screening and prenatal testing:
This article was originally published in Clinica
Executive Summary
The degree of current and prospective growth in the use of prenatal genetic testing has led the UK's Human Genetics Commission (HGC) to conclude that further consideration is needed to best regulate the technology. In a milestone report, published last week, the commission said it would also monitor developments in national screening programmes. The 180-page report, "Inside Information - Balancing interests in the use of personal genetic data", puts the human subject at the top of the agenda. It is evidence of the growing awareness in the medical and clinical research communities of the high degree of sensitivity surrounding genetics, and the realisation that scientific progress involving the technology is inextricably dependent on the public's confidence in the system that regulates it. The HGC makes a range of recommendations concerning the need to adapt UK primary and secondary legislation to tighten this, and for the users of genetic information to become more closely involved with the scientific community.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.